In glioma cell lines, NOSC inhibited the hypoxia-inducible factor-1 (HIF-1) pathway that is related to angiogenesis and cancer severity by reducing HIF-1 gene and vascular endothelial growth factor (VEGF). This evidence concerns the gene VEGFA and central nervous system cancer.